| [1] |
|
| [2] |
|
| [3] |
Allderdice PW, Davis JG, Miller OJ, et al. The 13q-deletion syndrome[J]. Am J Hum Genet, 1969, 21(5): 499-512.
|
| [4] |
Brown S, Gersen S, Anyane-Yeboa K, et al. Preliminary definition of a " critical region" of chromosome 13 in q32: report of 14 cases with 13q deletions and review of the literature[J]. Am J Med Genet, 1993, 45(1): 52-59. DOI: 10.1002/ajmg.1320450115.
|
| [5] |
Brown S, Russo J, Chitayat D, et al. The 13q-syndrome: the molecular definition of a critical deletion region in band 13q32[J]. Am J Hum Genet, 1995, 57(4): 859-866.
|
| [6] |
Gürkan H, Atli Ei, Atli E, et al. Chromosomal microarray analysis in Turkish patients with unexplained developmental delay and intellectual developmental disorders[J]. Noro Psikiyatr Ars, 2020, 57(3): 177-191. DOI: 10.29399/npa.24890.
|
| [7] |
Shin S, Yu N, Choi JR, et al. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder[J]. Ann Lab Med, 2015, 35(5): 510-518. DOI: 10.3343/alm.2015.35.5.510.
|
| [8] |
Shao L, Shaw CA, Lu XY, et al. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5，380 casesb[J]. Am J Med Genet A, 2008, 146A(17): 2242-2251. DOI: 10.1002/ajmg.a.32399.
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2021, 23(11): 2230. DOI： 10.1038/s41436-019-0686-8.
|
| [13] |
Quélin C, Bendavid C, Dubourg C, et al. Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress[J]. Eur J Med Genet, 2009, 52(1): 41-46. DOI： 10.1016/j.ejmg.2008.10.002.
|
| [14] |
Matute E, Inozemtseva O, Aguilar-Lemarroy A, et al. Cognitive and behavioral phenotype of a young man with a chromosome 13 deletion del(13)(q21.32q31.1)[J]. Cogn Behav Neurol, 2012, 25(3): 154-158. DOI: 10.1097/WNN.0b013e31826dfd3c.
|
| [15] |
Morales JA, Mendizabal AP, Vásquez AI, et al. Interstitial deletion of 13q22-->q31: case report and review of the literature[J]. Clin Dysmorphol, 2006, 15(3): 139-143. DOI: 10.1097/01.mcd.0000204990.46743.7b.
|
| [16] |
Bisgaard AM, Kirchhoff M, Tümer Z, et al. Additional chromosomal abnormalities in patients with a previously detected abnormal karyotype, mental retardation, and dysmorphic features[J]. Am J Med Genet A, 2006, 140(20): 2180-2187. DOI: 10.1002/ajmg.a.31425
|
| [17] |
Grigori P, Panayiotou E, Sismani C, et al. 21 Mb deletion in chromosome band 13q22.2q32.1 associated with mild/moderate psychomotor retardation, growth hormone insufficiency, short neck, micrognathia, hypotonia, dysplastic ears and other dysmorphic features[J]. Eur J Med Genet, 2011, 54(3): 365-368. DOI: 10.1016/j.ejmg.2011.02.006.
|
| [18] |
Li MW, Zou XY, Zou CC. 13q22.1-q32.1 microdeletion syndrome[J]. Indian J Pediatr, 2019, 86(3): 303-305. DOI: 10.1007/s12098-018-2789-7.
|
| [19] |
Tészás A, Meijer R, Scheffer H, et al. Expanding the clinical spectrum of MYCN-related Feingold syndrome[J]. Am J Med Genet A, 2006, 140(20): 2254-2256. DOI: 10.1002/ajmg.a.31407.
|
| [20] |
de Pontual L, Yao E, Callier P, et al. Germline deletion of the miR-17-92 cluster causes skeletal and growth defects in humans[J]. Nat Genet, 2011, 43(10): 1026-1030. DOI: 10.1038/ng.915.
|
| [21] |
Kirchhoff M, Bisgaard AM, Stoeva R, et al. Phenotype and 244k array-CGH characterization of chromosome 13q deletions: an update of the phenotypic map of 13q21.1-qter[J]. Am J Med Genet A, 2009, 149A(5): 894-905. DOI: 10.1002/ajmg.a.32814.
|
| [22] |
Webb BD, Evans A, Naidich TP, et al. Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremor[J]. Hum Mutat, 2021, 42(6): 685-693. DOI: 10.1002/humu.24201.
|